{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:44:21Z","timestamp":1790837061981,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bjorl.2026.101768","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:01:43Z","timestamp":1768712503000},"page":"101768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-8194","authenticated-orcid":false,"given":"Antonio","family":"Moffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"de Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domiziana","family":"Nardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7174-8126","authenticated-orcid":false,"given":"Antonella","family":"Loperfido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-5331","authenticated-orcid":false,"given":"Peter","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuele","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2026.101768_bib0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","article-title":"Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis","volume":"132","author":"Nagarkar","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.bjorl.2026.101768_bib0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.bjorl.2026.101768_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115972","article-title":"Thymic stromal lymphopoietin and tezepelumab in airway diseases: from physiological role to target therapy","volume":"25","author":"Bagnasco","year":"2024","journal-title":"Int J Mol Sci."},{"issue":"Suppl S29","key":"10.1016\/j.bjorl.2026.101768_bib0020","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology."},{"key":"10.1016\/j.bjorl.2026.101768_bib0025","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.bjorl.2026.101768_bib0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/all.12577","article-title":"Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities","volume":"70","author":"Shi","year":"2015","journal-title":"Allergy."},{"key":"10.1016\/j.bjorl.2026.101768_bib0035","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jaci.2017.09.009","article-title":"Chronic rhinosinusitis in Asia","volume":"140","author":"Zhang","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.bjorl.2026.101768_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18787\/jr.2025.00002","article-title":"Biologics for chronic rhinosinusitis with nasal polyps: current status and clinical considerations in Korea","volume":"32","author":"Lee","year":"2025","journal-title":"J Rhinol."},{"key":"10.1016\/j.bjorl.2026.101768_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1945892419884789","article-title":"The 22-item sinonasal outcome test as a tool for the assessment of quality of life and symptom control in allergic rhinitis","volume":"34","author":"Husain","year":"2020","journal-title":"Am J Rhinol Allergy."},{"key":"10.1016\/j.bjorl.2026.101768_bib0050","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjorl.2026.101768_bib0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J Asthma Allergy."},{"issue":"4","key":"10.1016\/j.bjorl.2026.101768_bib0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40265-022-01679-2","article-title":"Tezepelumab: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs."},{"key":"10.1016\/j.bjorl.2026.101768_bib0065","unstructured":"FDA approves maintenance treatment for severe asthma | FDA. Accessed May 8, 2025. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-maintenance-treatment-severe-asthma#."},{"key":"10.1016\/j.bjorl.2026.101768_bib0070","unstructured":"Tezspire | European Medicines Agency (EMA). Accessed May 8, 2025. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tezspire."},{"key":"10.1016\/j.bjorl.2026.101768_bib0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.alit.2022.11.006","article-title":"Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma","volume":"72","author":"Kurihara","year":"2023","journal-title":"Allergol Int."},{"key":"10.1016\/j.bjorl.2026.101768_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.bjorl.2026.101768_bib0085","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12325-024-03006-5","article-title":"Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 domain and symptom-specific scores in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps","volume":"42","author":"Jacobs","year":"2025","journal-title":"Adv Ther."},{"key":"10.1016\/j.bjorl.2026.101768_bib0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/JAA.S413064","article-title":"Tezepelumab efficacy in patients with severe, uncontrolled asthma with comorbid nasal polyps in NAVIGATOR","volume":"16","author":"Laidlaw","year":"2023","journal-title":"J Asthma Allergy."}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869426000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869426000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:17:31Z","timestamp":1777015051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869426000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1808869426000170"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2026.101768","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2026.101768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial.","name":"copyright","label":"Copyright"}],"article-number":"101768"}}